Stay updated on Opregen in Geographic Atrophy Clinical Trial
Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page
- Check6 days agoChange DetectedAdministrative updates show new update dates in February 2026 (2026-02-17, 2026-02-13, 2026-02) and corresponding deletions from January 2026 (2026-01-15, 2026-01-14, 2026-01). There is no evidence of changes to the study design, endpoints, eligibility criteria, enrollment, or recruitment locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site now displays Revision: v3.4.2, and the funding-status notice as well as the previous Revision: v3.4.1 text have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide government funding notice was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedA glossary toggle was added and some page metadata text was updated or removed (e.g., Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedNew site added: Sierra Eye Associates in Reno, Nevada. The total number of locations is updated from 15 to 16.SummaryDifference0.5%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 removed on the page; this is a minor metadata update and does not change study content, eligibility criteria, or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.